版本:
中国

BRIEF-Nantkwest announces FDA grant of orphan drug designation

March 20 Nantkwest Inc:

* Nantkwest announces FDA grant of orphan drug designation for the company's ank natural killer cell therapy in merkel cell carcinoma Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐